Where the Money Goes

You are here

ALSF Childhood Cancer Research Grants

With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.

Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.

You can learn about ALSF's grant review process here.

Support This Research

Jump to search filters

ALSF Funded Research Projects

Project Title	Institution / Principal Investigator(s)	Grant Type	Year	State
Characterizing Resistance Mechanisms to BET-Bromodomain Inhibition in MYC-amplified	Broad Institute / Rameen Beroukhim, MD,PhD	Innovation Grants	2015	Massachusetts
Small Molecule Inhibitors of ERG for Pediatric Leukemia and Sarcoma	University of Virginia, School of Medicine / John Bushweller, PhD	Innovation Grants	2015	Virginia
Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma	Children’s Hospital Los Angeles / Shahab Asgharzadeh, MD	Innovation Grants	2015	California
Synergistic Differentiation Therapy in Neuroblastoma	Duke University / Gerard Blobe, M.D./Ph.D	Innovation Grants	2015	North Carolina
Transcriptional Effectors of Activated RAS Signaling in Juvenile Myelomonocytic Leukemia	Boston Children’s Hospital / Alan Cantor, MD, PhD	Innovation Grants	2015	Massachusetts
Space-Time Analysis of the California Birth Cohort: 30 Years of Childhood Cancer	University of California Berkeley / Steve Selvin, PhD	Epidemiology Grants	2015	California
Single Cell Analysis of Leukemia Initiation	Stanford University / Michael Cleary, MD	Innovation Grants	2015	California
Pharmacogenomics and Drug Screening Lead to a Novel Targeted Therapy with Potent and Specific Activity Against Mouse Models of MYCN-amplified Neuroblastoma	Virginia Commonwealth University / Anthony Faber, MD & Yael Mosse, MD (CHOP)	Innovation Grants	2015	Virginia
Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy	University of North Carolina / Timothy Gershon, MD, PhD	Innovation Grants	2015	North Carolina
Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma	Children’s Hospital Los Angeles / Robert Seeger, MD & Alan Wayne, MD	Innovation Grants	2015	California

Pages